ADIPOQ and Alzheimer disease: Activating AMPK can suppress GSK-3β action on Tau phosphorylation, whereas chronic adiponectin deficiency fails to phosphorylate AMPK, which in turn, enables GSK3β action on promoting Tau hyperphosphorylation, and subsequently results in AD-like neuropathology [19].